{"id":"W2766244916","doi":"10.1161/circ.132.suppl_3.12509","title":"Abstract 12509: Initial Reports on the Safety of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Novel Oral Anticoagulants (NOACs)","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Dabigatran; Warfarin; Stroke (engine); Edoxaban; Tissue plasminogen activator; Modified Rankin Scale; Internal medicine; Anticoagulant; Odds ratio; Anesthesia; Atrial fibrillation; Ischemic stroke; Ischemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003706167,0.0002857549,0.0004034083,0.001616856,0.0003698871,0.001169055,0.0005594429,0.0005915198,0.004001074],"category_scores_gemma":[0.02062338,0.0002031556,0.0005361499,0.002305499,0.0004324433,0.0005308616,0.0006175075,0.0006176953,0.0009041741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006915375,"about_ca_system_score_gemma":0.0008992159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003961071,"about_ca_topic_score_gemma":0.003666001,"domain_scores_codex":[0.995643,0.0009784729,0.001305811,0.000450614,0.001439181,0.000182805],"domain_scores_gemma":[0.970492,0.009761904,0.01302417,0.001260641,0.004789749,0.0006714715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009778721,0.0001029027,0.9720291,0.0005819767,0.0003227092,0.0004561893,0.0002350679,0.00004917418,0.0005521587,0.0001133168,0.004041172,0.02053845],"study_design_scores_gemma":[0.00006200534,0.0003335235,0.9891971,0.0002744131,0.0002960949,0.001306338,0.0002782551,0.0001216629,0.0005924547,0.00007545866,0.007444666,0.00001805148],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9553666,0.0199959,0.0008641637,0.002864941,0.0003050477,0.000128331,0.007521364,0.00004786525,0.0129059],"genre_scores_gemma":[0.9873617,0.004745631,0.0005523745,0.00104322,0.0006187817,0.00005195512,0.004818758,0.00001942166,0.0007883047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004001074,"threshold_uncertainty_score":0.01960033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04565168013339759,"score_gpt":0.2994435314698434,"score_spread":0.2537918513364458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}